Japan Researchers Said To Violate Ethics In Blood Study
This article was originally published in PharmAsia News
Executive Summary
Japanese researchers who published a study on molecular treatments for blood disorders such as leukemia apparently falsified their report, according to University of Tokyo officials. Officials said the researchers failed to follow ethics guidelines in conducting their study, which included drawing bone marrow and peripheral blood from five acute myeloid leukemia patients without their permission and without ethics board approval. The school said the investigation would continue and the article in question had been retracted. (Click here for more
You may also be interested in...
Second EU MDR Notified Body Designated In France
Four years after the designation of the first notified body in France under the Medical Device Regulation, AFNOR Certification has been named too.
Takeda, Astellas Found New JV To Support Japanese Bioventures
Major Japanese companies Takeda, Astellas and SMBC are joining hands to establish a new joint venture with $3.9m capital and based in Japan’s largest biocluster Shonan iPark to help incubate local biopharma start-ups.
Could Eledon’s Anti-CD40L Change Transplant Medicine?
Eledon Pharmaceuticals’ CD40 Ligand blocker has yielded impressive results for post-transplant immunosuppression and cutting-edge transplant doctors have also used it for pig-to-human kidney and heart transplants, opening up the field of xenotransplantation.